Cardinal roles of miRNA in cardiac development and disease

Science China Life Sciences

Volumn 54, Issue 12, 2011, Pages 1113-1120

  Feng, Yu Liang ^a,b   Yu, Xi Yong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

cardiac; development; disease; miRNA

Indexed keywords

MICRORNA;

GROWTH, DEVELOPMENT AND AGING; HEART; HEART DISEASE; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

HEART; HEART DISEASES; HUMANS; MICRORNAS;

EID: 84855542719     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4257-8     Document Type: Review

References (73)

1. De Rosa S, Fichtlscherer S, Lehmann R, et al. Transcoronary concentration gradients of circulating microRNAs. Circulation, 2011, 124: 1936-1944.
2. Kiriakidou M, Tan G S, Lamprinaki S, et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell, 2007, 129: 1141-1151.
3. Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 2005, 122: 553-563.
4. Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res, 2011, 109: 334-347.
5. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol, 2002, 12: 735-739.
6. Chendrimada T P, Gregory R I, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436: 740-744.
7. Sayed D, Hong C, Chen I Y, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res, 2007, 100: 416-424.
8. Tatsuguchi M, Seok H Y, Callis T E, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 2007, 42: 1137-1141.
9. van Rooij E, Sutherland L B, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006, 103: 18255-18260.
10. Darnell D K, Kaur S, Stanislaw S, et al. MicroRNA expression during chick embryo development. Dev Dyn, 2006, 235: 3156-3165.
11. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436: 214-220.
12. Zhao Y, Ransom J F, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 2007, 129: 303-317.
13. Sokol N S, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev, 2005, 19: 2343-2354.
14. Costantini D L, Arruda E P, Agarwal P, et al. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell, 2005, 123: 347-358.
15. Liu N, Bezprozvannaya S, Williams A H, et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev, 2008, 22: 3242-3254.
16. Levy D, Garrison R J, Savage D D, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 1990, 322: 1561-1566.
17. Rajabi M, Kassiotis C, Razeghi P, et al. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev, 2007, 12: 331-343.
18. van Rooij E, Sutherland L B, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006, 103: 18255-18260.
19. Chen J F, Murchison E P, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA, 2008, 105: 2111-2116.
20. Cheng Y, Ji R, Yue J, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol, 2007, 170: 1831-1840.
21. Sayed D, Hong C, Chen I Y, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res, 2007, 100: 416-424.
22. Ikeda S, Kong S W, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics, 2007, 31: 367-373.
23. Tatsuguchi M, Seok H Y, Callis T E, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 2007, 42: 1137-1141.
24. Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 2007, 116: 258-267.
25. Olson E N, Schneider M D. Sizing up the heart: development redux in disease. Genes Dev, 2003, 17: 1937-1956.
26. Tay Y, Zhang J, Thomson A M, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 2008, 455: 1124-1128.
27. Wilkins B J, Molkentin J D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun, 2004, 322: 1178-1191.
28. Lin Z, Murtaza I, Wang K, et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA, 2009, 106: 12103-12108.
29. Ikeda S, He A, Kong S W, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol, 2009, 29: 2193-2204.
30. Da C M P, Salic K, Gladka M M, et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol, 2010, 12: 1220-1227.
31. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med, 2007, 13: 613-618.
32. van Rooij E, Sutherland L B, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316: 575-579.
33. Callis T E, Pandya K, Seok H Y, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest, 2009, 119: 2772-2786.
34. Nishi H, Ono K, Horie T, et al. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol, 2011, 31: 744-755.
35. Ago T, Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal, 2007, 9: 679-687.
36. Yang Y, Ago T, Zhai P, et al. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res, 2011, 108: 305-313.
37. Wu K H, Mo X M, Han Z C, et al. Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg, 2011, 92: 1917-1925.
38. Mann D L, Bogaev R, Buckberg G D. Cardiac remodelling and myocardial recovery: lost in translation? Eur J Heart Fail, 2010, 12: 789-796.
39. Ren X P, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 2009, 119: 2357-2366.
40. Zhang X, Wang X, Zhu H, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol, 2010, 49: 841-850.
41. Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem, 2009, 284: 29514-29525.
42. Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci, 2007, 120: 3045-3052.
43. Shan Z X, Lin Q X, Fu Y H, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun, 2009, 381: 597-601.
44. Rowland R T, Meng X, Cleveland J C, et al. Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis. J Surg Res, 1997, 71: 155-160.
45. Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74: 1124-1136.
46. Rane S, He M, Sayed D, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res, 2009, 104: 879-886.
47. Lim J H, Lee Y M, Chun Y S, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell, 2010, 38: 864-878.
48. Qian L, van Laake L W, Huang Y, et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med, 2011, 208: 549-560.
49. Wang J X, Jiao J Q, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med, 2011, 17: 71-78.
50. Di Diego J M, Antzelevitch C. Ischemic ventricular arrhythmias: Experimental models and their clinical relevance. Heart Rhythm, 2011, 8: 1963-1968.
51. Mill J G, Stefanon I, Dos S L, et al. Remodeling in the ischemic heart: the stepwise progression for heart. Braz J Med Biol Res, 2011, 44: 890-898.
52. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med, 2007, 13: 486-491.
53. Lerner D L, Yamada K A, Schuessler R B, et al. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation, 2000, 101: 547-552.
54. Plaster N M, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2. 1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell, 2001, 105: 511-519.
55. Luo X, Lin H, Pan Z, et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem, 2008, 283: 20045-20052.
56. Michels G, Er F, Khan I, et al. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation, 2005, 111: 399-404.
57. Matkovich S J, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res, 2010, 106: 166-175.
58. Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010, 122: 2378-2387.
59. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9: 654-659.
60. Hunter M P, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 2008, 3: e3694.
61. Rabinowits G, Gercel-Taylor C, Day J M, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, 2009, 10: 42-46.
62. Camussi G, Deregibus M C, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int, 2010, 78: 838-848.
63. Kogure T, Lin W L, Yan I K, et al. Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology, 2011, 54: 1237-1248.
64. Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39: 7223-7233.
65. Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem, 2009, 55: 1944-1949.
66. Wang G K, Zhu J Q, Zhang J T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 2010, 31: 659-666.
67. D'Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J, 2010, 31: 2765-2773.
68. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun, 2010, 391: 73-77.
69. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond), 2010, 119: 87-95.
70. Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation, 2011, 124: 175-184.
71. Corsten M F, Dennert R, Jochems S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet, 2010, 3: 499-506.
72. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond), 2010, 119: 87-95.
73. Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet, 2011, 4: 446-454.